Nesuparib

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameNesuparib
Drug Alias NameJPI-547NOV-1402NOV-140201OCN-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTankyrase inhibitorsPoly (ADP-Ribose) polymerase inhibitorsWnt signalling pathway modulators
TargetsPoly (ADP-Ribose) polymeraseTankyrase
Therapy Area/IndicationsSolid tumoursEndometrial NeoplasmsGenital Neoplasms, Female +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJeil Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJeil Pharmaceutical Co LtdYonsei UniversityOnconic Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursEndometrial NeoplasmsGenital Neoplasms, Female +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A